FasterCures’ Post

“Distance as an Obstacle to Clinical Trial Access.” Nice article on the importance of making clinical trials more accessible. The new report is part of a broader effort by the Milken Institute FasterCures to increase access to and diversity in clinical Trials. #fastercures #patientsfirst #access #clinicaltrials

Very important article by Courtney Shihabuddin

Coming to a Delaware near you - Clinical Trial Availability State-wide. The latest example of how DHIN and our stakeholders are advancing the cause of medicine.

Diversity, equity and inclusion is a boardroom level issue across many facets of business. This blog highlights the importance of DE&I in clinical trials. Compelling insights from the Verana Health clinical trials team.

Happy Clinical Trials Day! Kenyetta Sims, MAOM, CCRC, our wonderful Manager of Research, shared the following about Clinical Trials.... Clinical Trials Day is celebrated globally each May 20 to recognize the day in 1774 that James Lind, a ship’s surgeon in the British Royal Navy, started what is often considered to be the first randomized clinical trial. In this case, it was to study the effects of different treatments on scurvy, a disease caused by a deficiency of vitamin C, and a major scourge for sailors on long voyages. Amazingly, Lind had found a cure for scurvy--after carrying out a clinical trial in only 12 people, of whom only two received the active treatment of citrus fruits. Many historians believe that the prevention and treatment of scurvy using citrus was the single most important factor in enhancing the physical health of the British fleet. This true story is intended to provide hope and solace to the thousands of clinical investigators who work every day--often unsuccessfully--to explore new treatments in medicine. Although these events occurred 250 years ago, clinical researchers will find Lind's experiences to be familiar. Initial enthusiasm is often based on sparse data, and early findings are typically regarded with skepticism by colleagues. Once established, it can take decades for the treatment to be widely adopted. When the life of a clinical research professional feels particularly challenging, the story of James Lind can provide encouragement to keep going! Access Community Health Network is committed to taking the best evidence-supported practices and learnings and applying them within our network. This has enabled us to be at the forefront of things like - screening and treatment for substance use in primary care settings, integration of behavioral health into primary care, HIV treatment and prevention, and of course how to understand social needs in the context of health care and treatment. Recently, we completed QUARTET USA, a trial in collaboration with Dr. Mark Huffman and Dr. Jody Cioliono, among many other experts, compared monotherapy for hypertension with ultra-low dose, quad pill therapy. The main findings were recently published in Nature. https://lnkd.in/ghYq4T3v. For more information about research, evaluation, and innovation at ACCESS, as well as some of the articles and summaries of our work, please check out https://lnkd.in/gf4CzYbA.

There are many barriers affecting clinical trial access, which in turn can limit participant diversity. OMNY Health’s CEO Dr. Mitesh Rao believes this needs to change and offers five steps for life sciences companies to take to improve representation.  Number one in his new article in MedCity News – collect and analyze social determinants of health data. Read more here. https://lnkd.in/gPQu3JdS #clinicaltrialdiversity #SDOH #clinicaltrials

Mayo Clinic Proceedings has launched a comprehensive series, "Forward Thinking on Clinical Trials in Clinical Practice," running from August 2023 through April 2024. This insightful series dives into: 🔬 Pragmatic clinical trials. 💡 Decentralized clinical trials. 🤝 Community engagement. ⚖️ Addressing health inequities. 🔍 Ethical and regulatory challenges. Stay tuned for more highlights from this groundbreaking series! #ClinicalTrials #MedicalResearch #Healthcare

Mayo Clinic Proceedings has launched a comprehensive series, "Forward Thinking on Clinical Trials in Clinical Practice," running from August 2023 through April 2024. This insightful series dives into: 🔬 Pragmatic clinical trials. 💡 Decentralized clinical trials. 🤝 Community engagement. ⚖️ Addressing health inequities. 🔍 Ethical and regulatory challenges. Stay tuned for more highlights from this groundbreaking series! #ClinicalTrials #MedicalResearch #Healthcare

Clinical trials are stronger the more diverse the representative patient populations are, but there are often barriers that prevent them from happening. Here are five strategies to break down the barriers and promote diverse representation for more effective clinical trials. Read below. #HCRI #ClinicalTrials #Diversity #Healthcare

Mayo Clinic Proceedings has launched a comprehensive series, "Forward Thinking on Clinical Trials in Clinical Practice," running from August 2023 through April 2024. This insightful series dives into: 🔬 Pragmatic clinical trials. 💡 Decentralized clinical trials. 🤝 Community engagement. ⚖️ Addressing health inequities. 🔍 Ethical and regulatory challenges. Stay tuned for more highlights from this groundbreaking series! #ClinicalTrials #MedicalResearch #Healthcare